eScholarship
metadata only
UC Comments on Docket No. FDA-2021-N-0286 for “Protection of Human Subjects and Institutional Review Boards” (September 28, 2022)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- UC Comments in Response to FDA's Proposed Guidance for Sponsors, Investigators,and Institutional Review Boards on Key Information and Facilitating Understanding in Informed Consent (Docket Number: FDA-2022-D-2997)#629288
- UC Comments on FDA's Considerations for the Use of Real-World Data and Real-World Evidence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability (Docket No. FDA-2021-D-1214, December 9, 2021)#629324
- Differences in the EU regulations for biomedical research on humans and animals: an ethical analysis#223304
- How the new European data protection regulation affects clinical research and recommendations?#29979
- Context-Relative Norms Determine the Appropriate Type of Consent in Clinical Biobanks: Towards a Potential Solution for the Discrepancy between the General Data Protection Regulation and the European Data Protection Board on Requirements for Consent#29971
Record · ID 629312
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive